摘要:
In a line pressure control apparatus of a belt-drive CVT, a shift is achieved by varying V- groove widths of primary and secondary pulleys by a differential pressure between primary and secondary pulley pressures, originating from line pressure. The differential pressure is created by bringing a shift actuator, such as a step motor, into a control position corresponding to a target transmission ratio. The target transmission ratio is calculated based on a theoretical transmission ratio based on engine-and-vehicle operating conditions, taking account of a hardware response delay and a disturbance. The target transmission ratio is converted into a reference-model operative position, corresponding to a reference-model number-of-steps of the shift actuator. An actual transmission ratio is converted into an actual-transmission-ratio related operative position. Line pressure is corrected in a manner so as to reduce the positional deviation between the reference-model operative position and the actual-transmission-ratio related operative position.
摘要:
In a line pressure control apparatus of a belt-drive CVT, a shift is achieved by varying V-groove widths of primary and secondary pulleys by a differential pressure between primary and secondary pulley pressures, originating from line pressure. The differential pressure is created by bringing a shift actuator, such as a step motor, into a control position corresponding to a target transmission ratio. The target transmission ratio is calculated based on a theoretical transmission ratio based on engine-and-vehicle operating conditions, taking account of a hardware response delay and a disturbance. The target transmission ratio is converted into a reference-model operative position, corresponding to a reference-model number-of-steps of the shift actuator. An actual transmission ratio is converted into an actual-transmission-ratio related operative position. Line pressure is corrected in a manner so as to reduce the positional deviation between the reference-model operative position and the actual-transmission-ratio related operative position.
摘要:
The present invention provides a method for screening drugs for suppressing inflammasome activity, using macrophages derived from induced pluripotent stem cells (iPS cells) having mutant NLRP3 gene.
摘要:
An image forming apparatus sequentially transfers toner images formed on a plurality of photosensitive drums onto an intermediate transfer member or a transfer material to form an image. The image forming apparatus includes an intermediate transfer belt provided with electrical conductivity, and a power supply for applying a voltage to a current supply member contacting the outer circumferential surface of the intermediate transfer belt to pass a current from the current supply member to the plurality of photosensitive drums via the intermediate transfer belt, thus primarily transferring the toner images from the plurality of photosensitive drums onto the intermediate transfer belt.
摘要:
An image forming apparatus sequentially transfers toner images formed on a plurality of photosensitive drums onto an intermediate transfer member or a transfer material to form an image. The image forming apparatus includes an intermediate transfer belt provided with electrical conductivity, and a power supply for applying a voltage to a current supply member contacting the intermediate transfer belt to pass a current from the current supply member to the plurality of photosensitive drums via the intermediate transfer belt, thus generating electric discharge on the upstream side of each of primary transfer sections.
摘要:
The present invention relates to a method for selecting induced pluripotent stem (iPS) cells. More particularly, the present invention provides: a method for selecting an iPS cell, comprising the steps of: (1a) measuring the expression level of an exogenous nuclear reprogramming gene(s) in a test iPS cell; and (2a) selecting an iPS cell in which the expression level(s) of an exogenous nuclear reprogramming gene(s) is/are less than or equal to the expression level(s) in control iPS cells; and a method for selecting an iPS cell, comprising the steps of: (1b) measuring the expression level of an exogenous nuclear reprogramming gene(s) and the sum the expression levels of the exogenous nuclear reprogramming gene(s) and the corresponding endogenous gene iPS cell; and (2b) selecting an iPS cell in which the ratio of the expression level of an exogenous nuclear reprogramming gene(s) relative to the sum of the expression levels of the exogenous transgene(s) and the corresponding endogenous gene(s) is less than 1 to the ratio in the control iPS cell.
摘要:
An image forming apparatus sequentially transfers toner images formed on a plurality of photosensitive drums onto an intermediate transfer member or a transfer material to form an image. The image forming apparatus includes an intermediate transfer belt provided with electrical conductivity, and a power supply for applying a voltage to a current supply member contacting the outer circumferential surface of the intermediate transfer belt to pass a current from the current supply member to the plurality of photosensitive drums via the intermediate transfer belt, thus primarily transferring the toner images from the plurality of photosensitive drums onto the intermediate transfer belt.
摘要:
A semiconductor device includes: a mounted body in which a wiring pattern is formed on a first main surface; a semiconductor chip mounted on the surface of the mounted body on which the wiring pattern is formed; an underfill material which is filled between the mounted body and the semiconductor chip and forms a fillet on an outer peripheral part of the semiconductor chip; and an injection section which is disposed on the mounted body and on an outside of a side section, on which the fillet is formed to be longest, of four side sections defining a chip mount area on which the semiconductor chip is mounted, and guides the underfill material to between the mounted body and the semiconductor chip.
摘要:
A developing apparatus includes a developer carrying member rotatably provided for carrying a developer; a regulating member that has conductivity, and is provided to be capable of being in contact with the developer carrying member for regulating a amount of the developer carried by the developer carrying member; a power supply that applies voltage to the regulating member; a deformation detecting unit that detects information relating to the deformation of the developer carrying member; and a control unit that controls the power supply to apply a correction voltage when a deformed portion of the developer carrying member passes through the regulating member in order that the amount of the developer carried by the developer carrying member in the circumferential direction is in uniform based on a result of the detection by the deformation detecting unit.
摘要:
An object of the present invention is to provide a medicament and method which is useful for prevention and/or therapy of arterial wall injury. According to the present invention, there is provided a method for prevention and/or therapy of arterial wall injury which comprises a step of administering the pyrazolone derivative represented by the following formula (I) or the physiologically acceptable salt thereof, or the hydrate or solvate thereof in a preventively or therapeutically effective amount to mammals including humans: wherein R1 represents a hydrogen atom, an aryl group, an alkyl group, or an alkoxycarbonylalkyl group; R2 represents a hydrogen atom, an aryloxy group, an arylmercapto group, an alkyl group or a hydroxyalkyl group; or R1 and R2 are combined with each other to represent an alkylene group; and R3 represents a hydrogen atom, an alkyl group, a cycloalkyl group, a hydroxyalkyl group, a benzyl group, a naphthyl group, a phenyl group, or a phenyl group substituted with 1 to 3 substituents selected from the group consisting of an alkyl group, an alkoxy group, a hydroxyalkyl group, an alkoxycarbonyl group, an alkylmercapto group, an alkylamino group, a dialkylamino group, a halogen atom, a trifluoromethyl group, a carboxyl group, a cyano group, a hydroxyl group, a nitro group, an amino group and an acetamide group.
摘要翻译:本发明的目的是提供一种可用于预防和/或治疗动脉壁损伤的药物和方法。 根据本发明,提供了一种预防和/或治疗动脉壁损伤的方法,包括给予由下式(I)表示的吡唑啉酮衍生物或其生理学上可接受的盐,或其水合物或溶剂化物 其具有预防或治疗有效量的哺乳动物包括人:其中R 1表示氢原子,芳基,烷基或烷氧基羰基烷基; R 2表示氢原子,芳氧基,芳基巯基,烷基或羟烷基; 或R 1和R 2彼此结合以表示亚烷基; R 3表示氢原子,烷基,环烷基,羟基烷基,苄基,萘基,苯基或被1〜3个取代基取代的苯基 由烷基,烷氧基,羟基烷基,烷氧基羰基,烷基巯基,烷基氨基,二烷基氨基,卤素原子,三氟甲基,羧基,氰基, 羟基,硝基,氨基和乙酰胺基。